Literature DB >> 11145266

Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection.

L I Hor1, Y K Chang, C C Chang, H Y Lei, J T Ou.   

Abstract

Vibrio vulnificus produces fulminant septicemia in humans with underlying conditions, particularly those with diseases that elevate the iron level. The effect of a high iron level on the virulence of V. vulnificus was therefore investigated in mice treated with iron dextran. The mice loaded with iron became highly susceptible to V. vulnificus infection, the LD50 (50% lethal dose) decreased five logs when infected per peritoneum. However, when infected via the oral route, the LD50 was affected little unless the mouse was treated with an additional drug such as cyclophosphamide or D-galactosamine. Mice with or without iron-overloading died when the bacterial concentration in the blood reached 10(5) cfu/ml or above. Iron increased the growth rate of the bacteria, both inside and outside of the animal, quickly reaching a lethal concentration in the iron-overloaded mouse. V. vulnificus, grown with or without the addition of iron, showed strong cytotoxicity on the isolated cells or within the animal at high bacterial concentration. Iron overload stimulated the production of tumor necrosis factor alpha (TNF-alpha), a major factor of septic shock, in mice upon infection with the bacteria, probably caused by the endotoxin; however, the neutrophils, whose migration is effected by TNF-alpha, appeared to be less active. Taken together, the major virulence factor of V. vulnificus appeared to be the accelerated growth of bacteria to quickly reach the lethal level and the lower activity of immune cells including neutrophil as a result of iron-overloading. These two effects manifest other virulence factors, the host's as well as bacterial. Such factors, other than TNF-alpha stimulated by the endotoxin, enhanced cytotoxicity, which kills the host cells including the host's immune cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11145266     DOI: 10.1111/j.1348-0421.2000.tb02577.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  27 in total

1.  Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin.

Authors:  J J Fan; C P Shao; Y C Ho; C K Yu; L I Hor
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.

Authors:  Tae Hee Lee; Sun-Shin Cha; Chang-Seop Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 3.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

4.  Regulation of metalloprotease gene expression in Vibrio vulnificus by a Vibrio harveyi LuxR homologue.

Authors:  C P Shao; L I Hor
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

5.  Tumor necrosis factor-α and mortality in patients infected with Vibrio vulnificus.

Authors:  Jun-Young Lee; Dong-Min Kim; Na Ra Yun; Ganesh Prasad Neupane; Sook-In Jung; Kyung-Hwa Park; Hee Chang Jang; Chang Seop Lee; Sun Hee Lee
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

6.  The ttpC gene is contained in two of three TonB systems in the human pathogen Vibrio vulnificus, but only one is active in iron transport and virulence.

Authors:  Ryan J Kustusch; Carole J Kuehl; Jorge H Crosa
Journal:  J Bacteriol       Date:  2012-04-13       Impact factor: 3.490

7.  A common virulence plasmid in biotype 2 Vibrio vulnificus and its dissemination aided by a conjugal plasmid.

Authors:  Chung-Te Lee; Carmen Amaro; Keh-Ming Wu; Esmeralda Valiente; Yi-Feng Chang; Shih-Feng Tsai; Chuan-Hsiung Chang; Lien-I Hor
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

8.  Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.

Authors:  Chia-Chang Chuang; Yin-Ching Chuang; Wen-Teng Chang; Chi-Chung Chen; Lien-I Hor; A-Ming Huang; Pui-Ching Choi; Chi-Yun Wang; Po-Chin Tseng; Chiou-Feng Lin
Journal:  BMC Immunol       Date:  2010-10-12       Impact factor: 3.615

9.  Global gene expression as a function of the iron status of the bacterial cell: influence of differentially expressed genes in the virulence of the human pathogen Vibrio vulnificus.

Authors:  Alejandro F Alice; Hiroaki Naka; Jorge H Crosa
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

10.  Further characterization of Vibrio vulnificus rugose variants and identification of a capsular and rugose exopolysaccharide gene cluster.

Authors:  Brenda L Grau; Margaret C Henk; Katherine L Garrison; Brett J Olivier; Randall M Schulz; Kathy L O'Reilly; Gregg S Pettis
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.